Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/350
COVID-19 related social distancing measures and reduction in city mobility | |
Chandra Couzens Saad B Omer Amyn Abdul Malik | |
Novel Coronavirus | |
Acceso Abierto | |
Atribución-NoComercial | |
10.1101/2020.03.30.20048090 | |
In the absence of any pharmacological intervention, one approach to slowing the COVID-19 pandemic is reducing the contact rate in the population through social distancing. Governments the world over have instituted different measures to increase social distancing but information on their effectiveness in reducing mobility is lacking. We analyzed the mobility data from 41 cities to look at the effect of these interventions. The median mobility across cities on March 2, 2020 was 100% (IQR: 94%, 107%), which decreased to a median of 10% (IQR: 7%, 17%) on March 26, 2020. We found that the mobility decreased on average by 3.4% (95%CI: 3.3%, 3.6%) per day from March 2 through March 26. Social distancing measures decreased the mobility by an additional 23% (95%CI: 20%, 27%). Our study provides initial evidence for the reduction in mobility in cities instituting social distancing measures. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement No external funding was received for this work ### Author Declarations All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript. Yes All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes All data is publicly available and can also be requested from the corresponding author. | |
Cold Spring Harbor Laboratory Press | |
2020 | |
Preimpreso | |
https://www.medrxiv.org/content/10.1101/2020.03.30.20048090v1 | |
Inglés | |
VIRUS RESPIRATORIOS | |
Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
Fichero | Tamaño | Formato | |
---|---|---|---|
COVID-19 related.pdf | 81.44 kB | Adobe PDF | Visualizar/Abrir |